NASDAQ: SGP
Spyglass Pharma Inc Stock Forecast, Predictions & Price Target

Analyst price target for SGP

Based on 5 analysts offering 12 month price targets for Spyglass Pharma Inc

Min Forecast
$37.00+63.64%
Avg Forecast
$45.00+99.03%
Max Forecast
$62.00+174.21%

Should I buy or sell SGP stock?

Based on 5 analysts offering ratings for Spyglass Pharma Inc.

Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SGP's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SGP as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their SGP stock forecasts and price targets.

SGP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-10
lockedlocked$00.00+00.00%2026-03-03
lockedlocked$00.00+00.00%2026-03-03
lockedlocked$00.00+00.00%2026-03-03
lockedlocked$00.00+00.00%2026-03-03

1 of 1

Forecast return on equity

Is SGP forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is SGP forecast to generate an efficient return on assets?

SGP revenue forecast

What is SGP's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0

SGP vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SGP$22.61$45.00+99.03%Strong Buy
BVS$8.94$15.00+67.79%Buy
IART$9.20$12.40+34.78%Sell
CBLL$17.77$23.20+30.56%Strong Buy
INMD$13.40$15.50+15.67%Hold

Spyglass Pharma Stock Forecast FAQ

Is Spyglass Pharma Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: SGP) stock is to Strong Buy SGP stock.

Out of 5 analysts, 3 (60%) are recommending SGP as a Strong Buy, 2 (40%) are recommending SGP as a Buy, 0 (0%) are recommending SGP as a Hold, 0 (0%) are recommending SGP as a Sell, and 0 (0%) are recommending SGP as a Strong Sell.

If you're new to stock investing, here's how to buy Spyglass Pharma stock.

What is SGP's revenue growth forecast for 2026-2027?

(NASDAQ: SGP) Spyglass Pharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.29%.

Spyglass Pharma's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast SGP's revenue for 2026 to be $0, with the lowest SGP revenue forecast at $0, and the highest SGP revenue forecast at $0.

In 2027, SGP is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is SGP's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: SGP) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 11.78%.

What is SGP's Price Target?

According to 5 Wall Street analysts that have issued a 1 year SGP price target, the average SGP price target is $45.00, with the highest SGP stock price forecast at $62.00 and the lowest SGP stock price forecast at $37.00.

On average, Wall Street analysts predict that Spyglass Pharma's share price could reach $45.00 by Mar 10, 2027. The average Spyglass Pharma stock price prediction forecasts a potential upside of 99.03% from the current SGP share price of $22.61.

What is SGP's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: SGP) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.